Global /Philippines /Healthcare /Medical Devices /EURO
chevron_leftBack
Euro-Med Laboratories Phil., Inc. logo

Euro-Med Laboratories Phil., Inc.

EURO
PSE: EURO Delayed
1.02PHP -1%
0.0166 USD
As of 5 June 2026, Euro-Med Laboratories Phil., Inc. has a market cap of $67.79M USD, ranking #28340 globally and #140 in Philippines. It ranks #2567 in the Healthcare sector, and #523 in the Medical Devices industry.
Global Rank
28340
Country Rank
140
Sector Rank
2567
Industry Rank
523
Key Stats
Market Cap
$67.79MUSD
4.19B PHP
Enterprise Value
$113.6MUSD
6.99B PHP
Revenue (TTM)
$111.0MUSD
6.87B PHP
EBITDA (TTM)
$19.91MUSD
1.22B PHP
Net Income (TTM)
$7.6MUSD
470.3M PHP
EBITDA Margin
18%
Profit Margin
6.8%
PE Ratio
9.3
PS Ratio
0.6
PB Ratio
0.7
EV/EBITDA
5.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Georgiana Evidente open_in_new
Employees
1,811
Founded
1988
Website
euromedlab.net open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1% 3.9% 1% -1.9% 8.4% 18%

News

Loading...

Markets

Exchange Ticker Price
Philippine Stock Exchange
MIC: XPHS
PRIMARY
EURO
Euro-Med Laboratories Philippines Inc
ISIN: PHY2352T1098
Shares Out.:
4.112B1 Shares Float: 579.602M2
TV:
SA:
YF:
GF:
BA:
MS:
1.02 PHP
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Euro-Med Laboratories Phil., Inc.

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injection; irrigation solutions, which are sterile solutions that are used to bathe and flush open wounds or body cavities; mannitol injection, an osmotic diuretic, which promotes the excretion of water; Dextran 70, a fluid to expand blood volume; and Metronidazole for infections of gum and dental cavities, and pressure sores, as well as pelvic area, brain and lung, bones, gastrointestinal, genital tract, and blood infections. In addition, it provides other drug preparations, including Bacticide, which is used for disinfection of wounds, burns, lacerations, and abrasions, as well as for pre and post-operative disinfection; limulus amebocyte lysate test products; and ophthalmic products, as well as distributes medical venipuncture intravenous sets and non DEHP gravity administration sets. Further, the company is involved in the manufacture of distilled drinking water; toll manufacture of pharmaceutical products in liquid form; operation of dialysis centers, restaurants, and bakeries; and provision of food, catering, food production, and other related services. It serves hospitals, clinics, drugstores, medical distributors, and traders, as well as corporate/industrial accounts. The company was incorporated in 1988 and is based in Manila, the Philippines. Euro-Med Laboratories Phil., Inc. operates as a subsidiary of U.S. Automotive Co., Inc.

Similar Companies

Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
256K%
25.8
$160.73B
237K%
56.7
$159.07B
235K%
25.6
DHR
$126.55B
187K%
34.7
SYK
$120.69B
178K%
38.3
MDT
$101.9B
150K%
22.2
chevron_leftBack